Self-monitoring of blood glucose (SMBG): comparison of no SMBG, SMBG alone and SMBG with telecare

Conditions

Topic: Diabetes

Sharon Parsons, Stephen D. Luzio, Jeremy N. Harvey, Stephen C. Bain, WY Cheung et al. (7 authors)

Diabetic Medicine2019-01-1740 citations

Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.

Parsons S, Luzio S, Bain S, Harvey J, McKenna J, Khan A, Rice S, Watkins A, Owens DR.

2017-01-2610 citations

10.1186/s12902-017-0154-x

Interventions

Participants will be randomised into one of the following three groups: Group 1: no self monitoring of blood glucose (SMBG), usual diabetes care, general diabetes education via bookle

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes mellitus patients with a duration of diabetes > 1 year 2. Age 18-80 years 3. HbA1c levels between =7.5% and =13% 4. Willing and able to provide informed consent 5. Access to a telephone 6. Able to make blood glucose measurements Target Gender: Male & Female; Upper Age Limit 80 years ; Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: 1. Diabetes other than type 2 diabetes mellitus (e.g., GAD positive) or treated with insulin 2. Pregnancy 3. Gestational diabetes mellitus 4. Severe chronic hepatic disease 5. Need to use SMBG as part of clinical care 6. Participation in any investigational drug trial within 1 month prior to Visit 1 7. Mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study 8. End-stage renal disease (existing or planned dialysis or transplantation) or creatinine >150 umol/L 9. Blindness or severe loss of visual acuity in both eyes

Design outcomes

Primary

Measure	Time frame
HbA1c result; Timepoint(s): at 12 months	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed